Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.16

+0.02 (+1.32%)

As of Aug 15, 2:05 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +3,034.2% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $1.16

Current
$1.16

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

2,042.9%

Low target

Base Case

$36.20

+3,034.2%

Avg target

Bull Case

$54.95

+4,657.6%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.62

-55.8% from high

52-Week Low

$0.92

+25.5% from low

Target vs 52W High

$36.20

+1,283.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%